Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

Full Article
Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

Mendaera, Inc. has successfully closed a $73 million Series B funding round, led by Threshold Ventures. This funding aims to advance the development of a handheld robotic interventional platform that integrates robotics and AI for mainstream medical procedures. The initiative addresses critical healthcare challenges, including rising costs and labor shortages, by making advanced technology accessible for everyday medical interventions.

The funding will enable Mendaera to enhance its robotic technology and AI capabilities, ultimately improving patient care and operational efficiency. By focusing on commonly performed procedures, Mendaera seeks to alleviate bottlenecks in healthcare delivery and enhance the overall patient experience. The collaboration with notable investors and the acquisition of telepresence technology further solidify Mendaera's position in the evolving landscape of medical robotics.

• Mendaera's funding will scale robotics and AI in medical procedures.

• The handheld platform aims to improve everyday medical interventions.

Key AI Terms Mentioned in this Article

Robotics

Mendaera is pioneering the use of robotics in everyday medical procedures to enhance care delivery.

Artificial Intelligence (AI)

Mendaera's platform integrates AI to improve the efficiency and effectiveness of medical interventions.

Telepresence Technology

Mendaera's acquisition of telepresence technology from Avail Medsystems enhances its platform's connectivity capabilities.

Companies Mentioned in this Article

Mendaera

Mendaera aims to revolutionize everyday medical procedures through advanced robotics and AI.

Threshold Ventures

Threshold Ventures leads Mendaera's funding round to support its innovative healthcare solutions.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics